Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Alnylam Pharmaceuticals (ALNY) Q1 2017 Earnings
ALNY
8
Feb
Confirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-1.37
-1.26
-1.16
-1.05
Details
Expected EPS
-1.37
Actual EPS
-1.32
Surprise EPS
0.05
Surprise Percent
+3.65%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.32 per share for Q1 2017.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login